Skip to content

13F-HR filed by Eleva Capital SAS

Eleva Capital SAS filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-07-02, with 24 holding rows worth $343,412,320 by the sum of the rows.

Accession
0002054496-26-000003
Filed
2026-07-02
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 22 entries on the cover page, a total value of $85,997,309 stated on the cover page (in dollars after the unit check, H1), rows summing to $343,412,320 with VALUE read as dollars as filed, 13F file number 028-25477. The quarter's positions are built on this report. The resolved quarter.

The cover page states a total of $85,997,309, 75% less than the sum of the rows, $343,412,320. This page uses the sum of the rows.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CRH PLC ORDG25508105Stock2,654,974$279,090,866dollars as filed
AMER SPORTS INCG0260P102COMMON STOCK298,802$9,836,562dollars as filed
NVIDIA Corp67066G104COM52,002$9,069,148dollars as filed
Netflix, Inc64110L106COM87,190$8,383,319dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM27,967$8,042,191dollars as filed
TAIWAN SEMICONDUCTOR MFG874039100SPONSORED ADS21,411$6,506,589dollars as filed
ARISTA NETWORKS INC040413205COM46,957$5,765,380dollars as filed
Amazon.com, Inc023135106COM16,155$3,364,601dollars as filed
T-Mobile US,Inc.872590104COM14,347$3,013,300dollars as filed
ROBINHOOD MKTS INC770700102COM31,625$2,191,613dollars as filed
ON HLDG AG NAMEN AKT AH5919C104Stock50,150$1,706,103dollars as filed
Boston Scientific Corporation101137107COM26,667$1,673,354dollars as filed
SPOTIFYTECHNOLOGYSAFL8681T102STOK2,715$1,316,531dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK25,721$823,329dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK8,289$561,000dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock183,047$501,549dollars as filed
MINERALYS THERAPEUTICS INC603170101COM17,081$462,724dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK53,234$327,389dollars as filed
DISC MEDICINE INC COM254604101Stock5,115$327,053dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM7,126$139,385dollars as filed
FREEPORT MCMORAN INC CL B35671D857Stock2,258$132,725dollars as filed
ARCHER AVIATION INC03945R102COM CL A21,534$111,331dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM17,460$54,990dollars as filed
AQUESTIVE THERAPEUTICS INC COM03843E104Stock2,720$11,288dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002054496-26-000003this filing2026-07-02acceptance time not in the bulk data set